The Biden administration plans to support a temporary waiver on patents and other intellectual property rules preventing developing countries from mass-producing generic COVID-19 vaccines, United States Trade Representative Katherine Tai announced on Wednesday.
A group of developing countries led by India and South Africa was pushing for the move, which comes as a relief for global public health advocates.
